Transcript Slide 1

URINE DRUG
TESTING &
MONITORING
For Workers’ Compensation
NCCI Reports
Pharmacy costs are 18% of
the total medical spending in
Worker’s Compensation
Based on adherence studies…
► Less than 30% of claimants take their
medications as prescribed
► More than 30% fill their medications but
do not take them
► More than 30% take additional
medications and/or substances that can
reduce or eliminate the efficacy of the
prescribed medications
Urine Drug Testing and Monitoring
can help determine exactly what
medications are being ingested
Adherence/Efficacy
All individuals are different:
Slow Metabolizers
Fast Metabolizers
Enzyme/Metabolizing
Two enzymes metabolize the
majority of opioids
Inability to Metabolize
►Inhibitors
►Enzyme mutation
Genetic Testing
►One test in a lifetime
►Determines individual’s metabolic rate
►Helps to create a more efficacious plan of care
Types of Urine Drug Testing
►Point of Care Testing (POCT)
►Enzyme Immunoassay (EIA)
►Gas Chromatography/Mass Spectrometry
(GC/MS)
►Ultra-Performance Liquid
Chromatography/Tandem Mass Spectrometry
(UPLC/MS/MS)
Picking The Right Laboratory
►Laboratory chain of custody
►Reporting, scientific evidence?
►Knowledgeable clinical services department
►Technology
►Science
Who Should Be Tested?
►Large drug spend
►Expensive and highly addictive drugs
►Extensive drug regimes
►Early refills, increase in dosage
►Settlement
►MSA
Hurdles to Testing
►The treating physician…
Uses
POCT
Uses a different lab
Dispenses out of office
Refuses to test
►Patient refuses
QUESTIONS?